drugset / Trial / NCT05873426
Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in China
NaSingle-groupOpen-labelBasic science
Summary
This study is a single-center, open-label, and single-dose clinical study to evaluate the mass balance, biotransformation and pharmacokinetics of \[14C\]ZSP1273 in healthy Chinese male participants, revealing the overall pharmacokinetic characteristics of ZSP1273.
Timeline
- Start
- 2023-03-25
- Primary completion
- 2023-04-28
- Completion
- 2023-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Onradivir | Small molecule | 600 mg | Oral |
Indications
No indication recorded.